Monitoring and adaptive resistance management in Australia for Bt-cotton: current status and future challenges.
In the mid-1990 s the Australian Cotton industry adopted an insect-resistant variety of cotton (Ingard) which expresses the Bt toxin Cry1Ac that is specific to a group of insects including the target Helicoverpa armigera. A conservative resistance management plan (RMP), that restricted the area planted to Ingard, was implemented to preserve the efficacy of Cry1Ac until two-gene transgenic cotton was available. In 2004/05 Bollgard II replaced Ingard as the transgenic cotton available in Australia. It improves on Ingard by incorporating an additional insecticidal protein (Cry2Ab). If an appropriate refuge is grown, there is no restriction on the area planted to Bollgard II. In 2004/05 and 2005/06 the Bollgard II acreage represented approximately 80 of the total area planted to cotton in Australia. The sensitivity of field-collected populations of H. armigera to Bt products was assayed before and subsequent to the widespread deployment of Ingard cotton. In 2002 screens against Cry2Ab were developed in preparation for replacement of Ingard with Bollgard II. There have been no reported field failures of Bollgard II due to resistance. However, while alleles that confer resistance to H. armigera in the field are rare for Cry1Ac, they are surprisingly common for Cry2Ab. We present an overview of the current approach adopted in Australia to monitor and adaptively manage resistance to Bt-cotton in field populations of H. armigera and discuss the implications of our findings to date. We also highlight future challenges for resistance management in Australia, many of which extend to other Bt-crop and pest systems.
Downes
Sharon
S
CSIRO Entomology and Australian Cotton Cooperative Research Centre, Locked Bag 59, Narrabri, NSW 2390, Australia. Sharon.Downes@csiro.au
Mahon
Rod
R
Olsen
Karen
K
D000383:Agriculture / Q000379:methods; D000818:Animals; D001315:Australia; D001413:Bacillus thuringiensis / Q000502:physiology*; D000083722:Bacillus thuringiensis Toxins; D001426:Bacterial Proteins / Q000235:genetics / Q000633:toxicity*; D001427:Bacterial Toxins / Q000235:genetics / Q000633:toxicity*; D004731:Endotoxins / Q000235:genetics / Q000633:toxicity*; D004784:Environmental Monitoring / Q000379:methods*; D005260:Female; D003368:Gossypium / Q000235:genetics*; D006460:Hemolysin Proteins / Q000235:genetics / Q000633:toxicity*; D007305:Insecticide Resistance / Q000187:drug effects* / Q000235:genetics; D007306:Insecticides / Q000633:toxicity*; D007814:Larva / Q000187:drug effects / Q000254:growth & development; D008297:Male; D009036:Moths / Q000187:drug effects / Q000254:growth & development; D010572:Pest Control, Biological / Q000379:methods; D030821:Plants, Genetically Modified
D000083722:Bacillus thuringiensis Toxins; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D004731:Endotoxins; D006460:Hemolysin Proteins; D007306:Insecticides; C030956:insecticidal crystal protein, Bacillus Thuringiensis